Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Acquisition expands Assemblin’s electrical engineering operations in Turku, Finland

Assemblin in Finland is acquiring the operations of electrical engineering company Sähköpalvelu J. Vainionpää Oy. With the acquisition, Assemblin is strengthening its position in Turku, expanding the current installation operations with additional electrical engineering expertise and approximately SEK 15 million in annual sales.Sähköpalvelu J. Vainionpää Oy (“Sähköpalvelu J. Vainionpää”), which was founded in 1992, employs ten electricians and operates mainly in Turku and its environs in south-western Finland. The company has annual sales of approximately SEK 15 million and works

Humana acquires individual and family company Kalliola Oy

Humana acquires the Finnish individual and family company Kalliola Oy. The acquisition will strengthen Humana’s position in the Helsinki Metropolitan Area region in Finland and will increase Humana’s capacity to provide care services for children, youth and adults as the needs in society is increasing.Kalliola Oy is part of the Kalliola Group and owned by the Kalliola Settlement Association which has operated in Finland for hundred years. Kalliola Oy provides child welfare services, housing services and open care services. Full-year revenues amount to approximately EUR 9 million,

BioStock: Chordate Medical closed 2021 with focus on Saudi Arabia

Patients with chronic nasal congestion in Saudi Arabia can receive full reimbursement for Chordate Medical’s K.O.S treatment, which was recently performed for the first time on a privately insured patient. In addition, Chordate Medical’s management has just returned from a business trip in Saudi Arabia where they visited several healthcare providers using K.O.S, as well as a big conference in Otolaryngology. BioStock contacted CEO Anders Weilandt to hear more about the business travel and progress in Saudi Arabia.Read the full article at biostock.se: https://www.biostock.se/en/2022/01/

Oterra continues its growth track with the acquisition of Food Ingredient Solutions

Oterra, the world’s leading supplier of natural colors, with the widest portfolio in the industry, continues its strong growth acceleration announcing today the acquisition of Food Ingredient Solutions.Founded in 1999, Food Ingredient Solutions is a leading American producer of colors and natural antioxidants, with a strong exposure to, and growth from, natural colors. The Company serves more than 400 customers annually and has two certified processing facilities located in Teterboro, New Jersey, and Marshfield, Missouri.Oterra continues its strong growth with multiple complementary bolt-

Clinical Laserthermia Systems AB Promotes Michael Magnani to President of its U.S Subsidiary, CLS Americas Inc.

Clinical Laserthermia Systems AB (publ) (CLS AB), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced it has promoted Mr. Michael Magnani to president of its U.S subsidiary Clinical Laserthermia Systems Americas Inc. (CLS Americas). Mr. Magnani previously served two years as the managing director and is succeeding Mr. Dan J. Mogren, who will be joining CLS Americas’ board of directors.CLS Americas is focused on supporting postmarket studies and managing the commercialization of the TRANBERG® | Thermal Therapy Systems as image-guided precision tools

Componenta Corporation: Managers’ Transactions

Componenta Corporation Stock Exchange Release, 3 January 2022 at 1.30 p.m. EET Componenta Corporation has received the following notification of managers’ transactions with Componenta’s shares. Person subject to the notification requirementName: Sivuranta, SamiPosition: Chief Executive OfficerIssuer: Componenta CorporationLEI: 5493000SDCOXVGZDWK18 Notification type: INITIAL NOTIFICATIONReference number: 5493000SDCOXVGZDWK18_20211230130416_28____________________________________________ Transaction date: 2021-12-30Venue not applicableInstrument type: SHAREISIN:

Componenta Corporation: Managers’ Transactions

Componenta Corporation Stock Exchange Release, 3 January 2022 at 1.30 p.m. EET Componenta Corporation has received the following notification of managers’ transactions with Componenta’s shares. Person subject to the notification requirementName: Mäkinen, PasiPosition: Other senior managerIssuer: Componenta CorporationLEI: 5493000SDCOXVGZDWK18 Notification type: INITIAL NOTIFICATIONReference number: 5493000SDCOXVGZDWK18_20211230130416_29____________________________________________ Transaction date: 2021-12-30Venue not applicableInstrument type: SHAREISIN:

Componenta Corporation: Managers’ Transactions

Componenta Corporation Stock Exchange Release, 3 January 2022 at 1.30 p.m. EET Componenta Corporation has received the following notification of managers’ transactions with Componenta’s shares. Person subject to the notification requirementName: Karppinen, MarkoPosition: Chief Financial OfficerIssuer: Componenta CorporationLEI: 5493000SDCOXVGZDWK18 Notification type: INITIAL NOTIFICATIONReference number: 5493000SDCOXVGZDWK18_20211230130416_30____________________________________________ Transaction date: 2021-12-30Venue not applicableInstrument type: SHAREISIN:

Inzile’s partner QEV Technologies chosen for Barcelona Electromobility HUB

The governments of Spain and Catalonia, together with the trade unions, endorse the electromobility HUB proposal made by QEV Technologies, of which Inzile AB (publ) (“Inzile”) owns 19,64 %. The HUB will be located in the previous Nissan factory in the Free Zone of the Port of Barcelona. Inzile is a direct part of the winning HUB proposal, and will therefore have all the facilities for design and scale production of its new vehicles at its disposal. It is a great bet by the Spanish authorities on QEV Technologies and Inzile. Spain has recently been granted more than EUR 3 Billion in

Doge Dash Token • What Is Doge Dash? Where To Buy Doge Dash Coin? Learn About Doge Dash In 2022

Doge Dash Overview > Doge Dash Token • What Is Doge Dash? Where To Buy Doge Dash Coin? Learn About Doge Dash In 2022Doge Dash is a Mario Run inspired gamewhere anyone can earn coins through skilled gameplay and contributions to the ecosystem. The aim of the game is simple. Dash as fast as you can through all ofthe 10 levels whilst collecting coins along theway. Successful players who complete all levels will be rewarded with the collected coins direct to their wallets. Simple. BUY DOGE DASH USING BINANCE  DogeDash is an answerto the question of howcrypto games and

Nordstjernan to invest in medtech company Ascilion

Nordstjernan is investing in Ascilion, a Swedish medtech company founded in 2012 and based in Stockholm, Sweden. Ascilion has developed and patented a technology that uses an array of hollow microneedles to extract the interstitial fluid (ISF) that surrounds the body’s cells and that is a good carrier of biomarkers. Ascilion’s technology has numerous fields of application, including within several branches of medical diagnostics. Nordstjernan will become the second largest owner in Ascilion and, as a partner to the company’s founder and current owners, the aim is to accelerate the company’s

Policy for Responsible investments 2022

Swedbank Robur continuously reviews its policies and strategies and updates their working guidelines, and as of the 1[st] of January 2022, the fund company has further strengthened its Policy for Responsible investments.Among other things, investments in the gambling sector are now excluded. The work on monitoring and reviewing the ongoing sustainability work is clarified, and the Exclusion strategy has been further sharpened. Several new Expectation Papers have also been established. "The continuous reviewing of our guidelines is an important part of our work. By sharpen and clarifying

Herantis Pharma to Participate in the Upcoming Investor Conferences

Herantis Pharma Plc, Press Release, 3 January 2022 at 12:45 EET Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases, today announced that Dr. Craig Cook, Chief Executive Officer, will hold 1x1 meetings and company presentations at the following investor conferences: H.C. Wainwright BioConnect Conference, US - January 10th - 13th, 2022 (Virtual) The presentation will be held on January 10[th] at 14:00 – 14:30 EET / 13:00 – 13:30 CET. 1x1 meetings will be scheduled during January 10-13[th]. Biotech Showcase, US -

Enersense specifies the timetable for the implementation of the P2X investment and partnership arrangement

Enersense International PlcStock exchange release 3 January 2022 at 12:15 p.m.In its release of 8 December 2021, Enersense International Plc (”Enersense”), a provider of zero-emission energy solutions, announced it had signed an agreement on a EUR 13–18 million equity investment in green hydrogen producer P2X Solutions Oy (”P2X”) and related partnership arrangement. The completion of the investment and partnership arrangement was conditional on P2X receiving a significant grant from the Ministry of Economic Affairs and Employment of Finland for the building of the Harjavalta production

Qt Group Plc: Share subscriptions based on stock options 2016

Qt Group Plc, stock exchange release,  3 January 2022, 12:00 noon  EETBetween 14 September and 9 December 2021, a total of 550 Qt Group Plc’s new shares has been subscribed for with the company's stock options 2016. For subscriptions made with the stock options 2016, the entire subscription price of EUR 2,662.00 will be entered in the reserve for invested unrestricted equity. After the trade registration the total amount of shares is 25,181,198. The shares subscribed for under the stock options 2016 have been registered in the Trade Register on 3 January 2022, as of which date the new

Nomination Committee Board Proposals for 2022

To the Annual General Meeting (AGM) on May 10, 2022, the Nomination Committee of Beijer Electronics Group AB has informed the company that it will be proposing following:· that the Board of Directors shall consist of six members. · re-election of Board members Bo Elisson, Ulrika Hagdahl, Johan Wester, Karin Gunnarsson and Lars Eklöf. · new election of Jonas Hård. · election of Bo Elisson as Chairman of the Board. Jonas Hård, born 1971, most recently held the position as Chief Digital Officer for Autoliv Group. Jonas holds an MBA from Henley Business School and General Management

Changes in Etteplan´s Management Group

Etteplan Oyj Stock Exchange Release January 3, 2022 at 11.00 a.m. EET Tero Leppänen, M.Sc. (Computer Science), has been appointed Senior Vice President, Software and Embedded Solutions and a member of Etteplan's Management Group. Leppänen has worked at Etteplan since 2016 in various leadership positions, most recently as Vice President, Testing and Product Verification Business Unit and member of Software and Embedded Solutions service area’s management team. Leppänen joined Etteplan through the acquisition of Espotel Oy in 2016 and prior to that Leppänen worked at Efore Oyj. “I

UPM participates in the Lux Helsinki light festival

(UPM, Helsinki, 03.01.2022 at 11.00 EET) – UPM and the UPM-Kymmene Cultural Foundation will participate in the Lux Helsinki light festival on 5–9 January, which will transform familiar buildings and spaces into unique works of urban art and illuminate the city during the darkest hours of the year. The exterior of UPM's headquarters will feature a 3D video projection by Soil Searchers Collective titled “Its Songs We Sing”, which also includes music. The artwork turns the public’s gaze to the basis of everything, the ground. It reminds us that there is a hidden biological world underground,

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 2 - 3 JANUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

DAMPSKIBSSELSKABET NORDEN A/S – WEEKLY REPORT ON SHARE BUY-BACK

ANNOUNCEMENT NO. 1 - 3 JANUARY 2022 On 4 November 2021, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 4 November 2021 up to and including no later than end February 2022. For details, please see announcement no. 75 of 4 November 2021. Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 40 million (approximately DKK 263 million).

Biotage moves to the large cap segment

As of today January 3, 2022, Biotage is included in Nasdaq Stockholm’s Large Cap segment. The Large Cap segment includes companies with a market capitalization of more than EUR 1 billion.Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development, analytical testing and water and environmental testing.Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.“Biotage continues to create value for our

BAKKAFROST: Bakkafrost has acquired 90% of the outstanding shares of Munkebo Seafood A/S

In a transaction closed on 1 January 2022, Bakkafrost has acquired 90% of the shares in Munkebo Seafood A/S. The deal was jointly made with Michael Karlsen, who has been the General Manager of Munkebo Seafood for the past many years. The shares were acquired from Paul Lybech, who has been engaged with Munkebo Seafood for almost 25 years. Following the transaction, Michael Karlsen holds 10% of the shares in Munkebo Seafood A/S while Bakkafrost holds 90% of the shares. Munkebo Seafood A/S was founded in 1974 and has since the formation been engaged in production of canned fish at the

Cantargia advances nadunolimab against pancreatic cancer in the PanCAN Precision Promise[SM] phase 2/3 clinical trial

Cantargia AB today announced that the Pancreatic Cancer Action Network’s (PanCAN) Precision Promise[SM] phase 2/3 clinical trial, carried out at leading clinical US centers, plans to include nadunolimab in combination with chemotherapy as first-line experimental therapy in metastatic pancreatic cancer (PDAC). The trial utilizes a Bayesian platform designed by PanCAN in collaboration with the US Food and Drug Administration (FDA) to provide a basis for marketing approval of therapies in PDAC. The primary endpoint for the trial is overall survival. PanCAN’s plan is to submit a Pre-IND

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 30th December 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,834,714 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

There are no items matching the current filter
There are no more items matching the current filter
Back to top